APO Research
Talk to an analyst

APO RESEARCH · REPORT

Avapritinib Tablets

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Avapritinib Tablets Market Analysis and Forecast 2026-2032

27 December 2025196 pages

Choose your research edition.

Industry ResearchAvapritinib Tablets Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Avapritinib Tablets Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal Avapritinib Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032170 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Avapritinib Tablets Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Avapritinib Tablets Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Avapritinib Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Avapritinib Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Avapritinib Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Avapritinib Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Avapritinib Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Avapritinib Tablets include Blueprint Medicines and CStone Pharmaceuticals etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Avapritinib Tablets, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Avapritinib Tablets, also provides the sales of main regions and countries. Of the upcoming market potential for Avapritinib Tablets, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Avapritinib Tablets sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Avapritinib Tablets market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Avapritinib Tablets sales, projected growth trends, production technology, application and end-user industry.

Avapritinib Tablets Segment by Company

Blueprint Medicines

CStone Pharmaceuticals

Avapritinib Tablets Segment by Type

100mg/pc

200mg/pc

300mg/pc

Others

Avapritinib Tablets Segment by Application

In-hospital Sales

Out-of-hospital Sales

Avapritinib Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Avapritinib Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Avapritinib Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Avapritinib Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Avapritinib Tablets in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Avapritinib Tablets manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Avapritinib Tablets sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Avapritinib Tablets Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 100mg/pc Major Manufacturers Table 3. 200mg/pc Major Manufacturers Table 4. 300mg/pc Major Manufacturers Table 5. Others Major Manufacturers Table 6. Global Avapritinib Tablets Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. In-hospital Sales Major Manufacturers Table 8. Out-of-hospital Sales Major Manufacturers Table 9. Avapritinib Tablets Industry Trends Table 10. Avapritinib Tablets Industry Drivers Table 11. Avapritinib Tablets Industry Opportunities and Challenges Table 12. Avapritinib Tablets Industry Restraints Table 13. Global Avapritinib Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Avapritinib Tablets Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Avapritinib Tablets Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Avapritinib Tablets Revenue Market Share by Region (2021-2026) Table 17. Global Avapritinib Tablets Revenue Market Share by Region (2027-2032) Table 18. Global Avapritinib Tablets Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Avapritinib Tablets Sales by Region (2021-2026) & (K Units) Table 20. Global Avapritinib Tablets Sales by Region (2027-2032) & (K Units) Table 21. Global Avapritinib Tablets Sales Market Share by Region (2021-2026) Table 22. Global Avapritinib Tablets Sales Market Share by Region (2027-2032) Table 23. Global Avapritinib Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Avapritinib Tablets Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Avapritinib Tablets Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Avapritinib Tablets Sales Market Share by Manufacturers (2021-2026) Table 27. Global Avapritinib Tablets Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Avapritinib Tablets Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Avapritinib Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Avapritinib Tablets Manufacturers, Product Type & Application Table 31. Global Avapritinib Tablets Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Avapritinib Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Avapritinib Tablets Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Avapritinib Tablets Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Avapritinib Tablets Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Avapritinib Tablets Revenue Market Share by Type (2021-2026) Table 38. Global Avapritinib Tablets Revenue Market Share by Type (2027-2032) Table 39. Global Avapritinib Tablets Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Avapritinib Tablets Sales by Type (2021-2026) & (K Units) Table 41. Global Avapritinib Tablets Sales by Type (2027-2032) & (K Units) Table 42. Global Avapritinib Tablets Sales Market Share by Type (2021-2026) Table 43. Global Avapritinib Tablets Sales Market Share by Type (2027-2032) Table 44. Global Avapritinib Tablets Price by Type (2021-2026) & (US$/Unit) Table 45. Global Avapritinib Tablets Price by Type (2027-2032) & (US$/Unit) Table 46. Global Avapritinib Tablets Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Avapritinib Tablets Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Avapritinib Tablets Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Avapritinib Tablets Revenue Market Share by Application (2021-2026) Table 50. Global Avapritinib Tablets Revenue Market Share by Application (2027-2032) Table 51. Global Avapritinib Tablets Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Avapritinib Tablets Sales by Application (2021-2026) & (K Units) Table 53. Global Avapritinib Tablets Sales by Application (2027-2032) & (K Units) Table 54. Global Avapritinib Tablets Sales Market Share by Application (2021-2026) Table 55. Global Avapritinib Tablets Sales Market Share by Application (2027-2032) Table 56. Global Avapritinib Tablets Price by Application (2021-2026) & (US$/Unit) Table 57. Global Avapritinib Tablets Price by Application (2027-2032) & (US$/Unit) Table 58. Blueprint Medicines Company Information Table 59. Blueprint Medicines Business Overview Table 60. Blueprint Medicines Avapritinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Blueprint Medicines Avapritinib Tablets Product Portfolio Table 62. Blueprint Medicines Recent Development Table 63. CStone Pharmaceuticals Company Information Table 64. CStone Pharmaceuticals Business Overview Table 65. CStone Pharmaceuticals Avapritinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. CStone Pharmaceuticals Avapritinib Tablets Product Portfolio Table 67. CStone Pharmaceuticals Recent Development Table 68. North America Avapritinib Tablets Revenue by Type (2021-2026) & (US$ Million) Table 69. North America Avapritinib Tablets Revenue by Type (2027-2032) & (US$ Million) Table 70. North America Avapritinib Tablets Sales by Type (2021-2026) & (K Units) Table 71. North America Avapritinib Tablets Sales by Type (2027-2032) & (K Units) Table 72. North America Avapritinib Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 73. North America Avapritinib Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 74. North America Avapritinib Tablets Revenue by Application (2021-2026) & (US$ Million) Table 75. North America Avapritinib Tablets Revenue by Application (2027-2032) & (US$ Million) Table 76. North America Avapritinib Tablets Sales by Application (2021-2026) & (K Units) Table 77. North America Avapritinib Tablets Sales by Application (2027-2032) & (K Units) Table 78. North America Avapritinib Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 79. North America Avapritinib Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 80. North America Avapritinib Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 81. North America Avapritinib Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 82. North America Avapritinib Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 83. North America Avapritinib Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 84. North America Avapritinib Tablets Sales by Country (2021-2026) & (K Units) Table 85. North America Avapritinib Tablets Sales by Country (2027-2032) & (K Units) Table 86. North America Avapritinib Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 87. North America Avapritinib Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 88. United States Avapritinib Tablets Revenue (2021-2032) & (US$ Million) Table 89. Canada Avapritinib Tablets Revenue (2021-2032) & (US$ Million) Table 90. Mexico Avapritinib Tablets Revenue (2021-2032) & (US$ Million) Table 91. Europe Avapritinib Tablets Revenue by Type (2021-2026) & (US$ Million) Table 92. Europe Avapritinib Tablets Revenue by Type (2027-2032) & (US$ Million) Table 93. Europe Avapritinib Tablets Sales by Type (2021-2026) & (K Units) Table 94. Europe Avapritinib Tablets Sales by Type (2027-2032) & (K Units) Table 95. Europe Avapritinib Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 96. Europe Avapritinib Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 97. Europe Avapritinib Tablets Revenue by Application (2021-2026) & (US$ Million) Table 98. Europe Avapritinib Tablets Revenue by Application (2027-2032) & (US$ Million) Table 99. Europe Avapritinib Tablets Sales by Application (2021-2026) & (K Units) Table 100. Europe Avapritinib Tablets Sales by Application (2027-2032) & (K Units) Table 101. Europe Avapritinib Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 102. Europe Avapritinib Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 103. Europe Avapritinib Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 104. Europe Avapritinib Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 105. Europe Avapritinib Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 106. Europe Avapritinib Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 107. Europe Avapritinib Tablets Sales by Country (2021-2026) & (K Units) Table 108. Europe Avapritinib Tablets Sales by Country (2027-2032) & (K Units) Table 109. Europe Avapritinib Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 110. Europe Avapritinib Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 111. Germany Avapritinib Tablets Revenue (2021-2032) & (US$ Million) Table 112. France Avapritinib Tablets Revenue (2021-2032) & (US$ Million) Table 113. U.K. Avapritinib Tablets Revenue (2021-2032) & (US$ Million) Table 114. Italy Avapritinib Tablets Revenue (2021-2032) & (US$ Million) Table 115. Russia Avapritinib Tablets Revenue (2021-2032) & (US$ Million) Table 116. Spain Avapritinib Tablets Revenue (2021-2032) & (US$ Million) Table 117. Netherlands Avapritinib Tablets Revenue (2021-2032) & (US$ Million) Table 118. Switzerland Avapritinib Tablets Revenue (2021-2032) & (US$ Million) Table 119. Sweden Avapritinib Tablets Revenue (2021-2032) & (US$ Million) Table 120. Poland Avapritinib Tablets Revenue (2021-2032) & (US$ Million) Table 121. China Avapritinib Tablets Revenue by Type (2021-2026) & (US$ Million) Table 122. China Avapritinib Tablets Revenue by Type (2027-2032) & (US$ Million) Table 123. China Avapritinib Tablets Sales by Type (2021-2026) & (K Units) Table 124. China Avapritinib Tablets Sales by Type (2027-2032) & (K Units) Table 125. China Avapritinib Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 126. China Avapritinib Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 127. China Avapritinib Tablets Revenue by Application (2021-2026) & (US$ Million) Table 128. China Avapritinib Tablets Revenue by Application (2027-2032) & (US$ Million) Table 129. China Avapritinib Tablets Sales by Application (2021-2026) & (K Units) Table 130. China Avapritinib Tablets Sales by Application (2027-2032) & (K Units) Table 131. China Avapritinib Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 132. China Avapritinib Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 133. Asia Avapritinib Tablets Revenue by Type (2021-2026) & (US$ Million) Table 134. Asia Avapritinib Tablets Revenue by Type (2027-2032) & (US$ Million) Table 135. Asia Avapritinib Tablets Sales by Type (2021-2026) & (K Units) Table 136. Asia Avapritinib Tablets Sales by Type (2027-2032) & (K Units) Table 137. Asia Avapritinib Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 138. Asia Avapritinib Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 139. Asia Avapritinib Tablets Revenue by Application (2021-2026) & (US$ Million) Table 140. Asia Avapritinib Tablets Revenue by Application (2027-2032) & (US$ Million) Table 141. Asia Avapritinib Tablets Sales by Application (2021-2026) & (K Units) Table 142. Asia Avapritinib Tablets Sales by Application (2027-2032) & (K Units) Table 143. Asia Avapritinib Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 144. Asia Avapritinib Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 145. Asia Avapritinib Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 146. Asia Avapritinib Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 147. Asia Avapritinib Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 148. Asia Avapritinib Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 149. Asia Avapritinib Tablets Sales by Country (2021-2026) & (K Units) Table 150. Asia Avapritinib Tablets Sales by Country (2027-2032) & (K Units) Table 151. Asia Avapritinib Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 152. Asia Avapritinib Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 153. Japan Avapritinib Tablets Revenue (2021-2032) & (US$ Million) Table 154. South Korea Avapritinib Tablets Revenue (2021-2032) & (US$ Million) Table 155. India Avapritinib Tablets Revenue (2021-2032) & (US$ Million) Table 156. Australia Avapritinib Tablets Revenue (2021-2032) & (US$ Million) Table 157. Taiwan Avapritinib Tablets Revenue (2021-2032) & (US$ Million) Table 158. Southeast Asia Avapritinib Tablets Revenue (2021-2032) & (US$ Million) Table 159. SAMEA Avapritinib Tablets Revenue by Type (2021-2026) & (US$ Million) Table 160. SAMEA Avapritinib Tablets Revenue by Type (2027-2032) & (US$ Million) Table 161. SAMEA Avapritinib Tablets Sales by Type (2021-2026) & (K Units) Table 162. SAMEA Avapritinib Tablets Sales by Type (2027-2032) & (K Units) Table 163. SAMEA Avapritinib Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 164. SAMEA Avapritinib Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 165. SAMEA Avapritinib Tablets Revenue by Application (2021-2026) & (US$ Million) Table 166. SAMEA Avapritinib Tablets Revenue by Application (2027-2032) & (US$ Million) Table 167. SAMEA Avapritinib Tablets Sales by Application (2021-2026) & (K Units) Table 168. SAMEA Avapritinib Tablets Sales by Application (2027-2032) & (K Units) Table 169. SAMEA Avapritinib Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 170. SAMEA Avapritinib Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 171. SAMEA Avapritinib Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 172. SAMEA Avapritinib Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 173. SAMEA Avapritinib Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 174. SAMEA Avapritinib Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 175. SAMEA Avapritinib Tablets Sales by Country (2021-2026) & (K Units) Table 176. SAMEA Avapritinib Tablets Sales by Country (2027-2032) & (K Units) Table 177. SAMEA Avapritinib Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 178. SAMEA Avapritinib Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 179. Brazil Avapritinib Tablets Revenue (2021-2032) & (US$ Million) Table 180. Argentina Avapritinib Tablets Revenue (2021-2032) & (US$ Million) Table 181. Chile Avapritinib Tablets Revenue (2021-2032) & (US$ Million) Table 182. Colombia Avapritinib Tablets Revenue (2021-2032) & (US$ Million) Table 183. Peru Avapritinib Tablets Revenue (2021-2032) & (US$ Million) Table 184. Saudi Arabia Avapritinib Tablets Revenue (2021-2032) & (US$ Million) Table 185. Israel Avapritinib Tablets Revenue (2021-2032) & (US$ Million) Table 186. UAE Avapritinib Tablets Revenue (2021-2032) & (US$ Million) Table 187. Turkey Avapritinib Tablets Revenue (2021-2032) & (US$ Million) Table 188. Iran Avapritinib Tablets Revenue (2021-2032) & (US$ Million) Table 189. Egypt Avapritinib Tablets Revenue (2021-2032) & (US$ Million) Table 190. Key Raw Materials Table 191. Raw Materials Key Suppliers Table 192. Avapritinib Tablets Distributors List Table 193. Avapritinib Tablets Customers List Table 194. Research Programs/Design for This Report Table 195. Authors List of This Report Table 196. Secondary Sources Table 197. Primary Sources List of Figures Figure 1. Avapritinib Tablets Image Figure 2. Global Avapritinib Tablets Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Avapritinib Tablets Market Size Share 2021 VS 2025 VS 2032 Figure 4. 100mg/pc Image Figure 5. 200mg/pc Image Figure 6. 300mg/pc Image Figure 7. Others Image Figure 8. Global Avapritinib Tablets Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Avapritinib Tablets Market Size Share 2021 VS 2025 VS 2032 Figure 10. In-hospital Sales Image Figure 11. Out-of-hospital Sales Image Figure 12. Global Avapritinib Tablets Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Avapritinib Tablets Revenue (2021-2032) & (US$ Million) Figure 14. Global Avapritinib Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Avapritinib Tablets Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Avapritinib Tablets Revenue Market Share by Region (2021-2032) Figure 17. Global Avapritinib Tablets Sales (2021-2032) & (K Units) Figure 18. Global Avapritinib Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Avapritinib Tablets Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Avapritinib Tablets Sales YoY (2021-2032) & (K Units) Figure 21. Europe Avapritinib Tablets Sales YoY (2021-2032) & (K Units) Figure 22. China Avapritinib Tablets Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Avapritinib Tablets Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Avapritinib Tablets Sales YoY (2021-2032) & (K Units) Figure 25. Global Avapritinib Tablets Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Avapritinib Tablets Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Avapritinib Tablets Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Avapritinib Tablets Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Avapritinib Tablets Revenue Market Share by Type (2021-2032) Figure 31. Global Avapritinib Tablets Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Avapritinib Tablets Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Avapritinib Tablets Sales Market Share by Type (2021-2032) Figure 34. Global Avapritinib Tablets Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Avapritinib Tablets Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Avapritinib Tablets Revenue Market Share by Application (2021-2032) Figure 37. Global Avapritinib Tablets Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Avapritinib Tablets Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Avapritinib Tablets Sales Market Share by Application (2021-2032) Figure 40. North America Avapritinib Tablets Revenue Share by Type (2021-2032) Figure 41. North America Avapritinib Tablets Sales Share by Type (2021-2032) Figure 42. North America Avapritinib Tablets Revenue Share by Application (2021-2032) Figure 43. North America Avapritinib Tablets Sales Share by Application (2021-2032) Figure 44. North America Avapritinib Tablets Revenue Share by Country (2021-2032) Figure 45. North America Avapritinib Tablets Sales Share by Country (2021-2032) Figure 46. Europe Avapritinib Tablets Revenue Share by Type (2021-2032) Figure 47. Europe Avapritinib Tablets Sales Share by Type (2021-2032) Figure 48. Europe Avapritinib Tablets Revenue Share by Application (2021-2032) Figure 49. Europe Avapritinib Tablets Sales Share by Application (2021-2032) Figure 50. Europe Avapritinib Tablets Revenue Share by Country (2021-2032) Figure 51. Europe Avapritinib Tablets Sales Share by Country (2021-2032) Figure 52. China Avapritinib Tablets Revenue Share by Type (2021-2032) Figure 53. China Avapritinib Tablets Sales Share by Type (2021-2032) Figure 54. China Avapritinib Tablets Revenue Share by Application (2021-2032) Figure 55. China Avapritinib Tablets Sales Share by Application (2021-2032) Figure 56. Asia Avapritinib Tablets Revenue Share by Type (2021-2032) Figure 57. Asia Avapritinib Tablets Sales Share by Type (2021-2032) Figure 58. Asia Avapritinib Tablets Revenue Share by Application (2021-2032) Figure 59. Asia Avapritinib Tablets Sales Share by Application (2021-2032) Figure 60. Asia Avapritinib Tablets Revenue Share by Country (2021-2032) Figure 61. Asia Avapritinib Tablets Sales Share by Country (2021-2032) Figure 62. SAMEA Avapritinib Tablets Revenue Share by Type (2021-2032) Figure 63. SAMEA Avapritinib Tablets Sales Share by Type (2021-2032) Figure 64. SAMEA Avapritinib Tablets Revenue Share by Application (2021-2032) Figure 65. SAMEA Avapritinib Tablets Sales Share by Application (2021-2032) Figure 66. SAMEA Avapritinib Tablets Revenue Share by Country (2021-2032) Figure 67. SAMEA Avapritinib Tablets Sales Share by Country (2021-2032) Figure 68. Avapritinib Tablets Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Avapritinib Tablets Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 100mg/pc
  • 200mg/pc
  • 300mg/pc
  • Others
Applications
  • In-hospital Sales
  • Out-of-hospital Sales
Companies covered
  • Blueprint Medicines
  • CStone Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Avapritinib Tablets Market by Type
  3. 1.2.1 Global Avapritinib Tablets Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 100mg/pc
  5. 1.2.3 200mg/pc
  6. 1.2.4 300mg/pc
  7. 1.2.5 Others
  8. 1.3 Avapritinib Tablets Market by Application
  9. 1.3.1 Global Avapritinib Tablets Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 In-hospital Sales
  11. 1.3.3 Out-of-hospital Sales
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Avapritinib Tablets Market Dynamics
  1. 2.1 Avapritinib Tablets Industry Trends
  2. 2.2 Avapritinib Tablets Industry Drivers
  3. 2.3 Avapritinib Tablets Industry Opportunities and Challenges
  4. 2.4 Avapritinib Tablets Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Avapritinib Tablets Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Avapritinib Tablets Revenue by Region
  3. 3.2.1 Global Avapritinib Tablets Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Avapritinib Tablets Revenue by Region (2021-2026)
  5. 3.2.3 Global Avapritinib Tablets Revenue by Region (2027-2032)
  6. 3.2.4 Global Avapritinib Tablets Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Avapritinib Tablets Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Avapritinib Tablets Sales by Region
  9. 3.4.1 Global Avapritinib Tablets Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Avapritinib Tablets Sales by Region (2021-2026)
  11. 3.4.3 Global Avapritinib Tablets Sales by Region (2027-2032)
  12. 3.4.4 Global Avapritinib Tablets Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Avapritinib Tablets Revenue by Manufacturers
  2. 4.1.1 Global Avapritinib Tablets Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Avapritinib Tablets Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Avapritinib Tablets Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Avapritinib Tablets Sales by Manufacturers
  6. 4.2.1 Global Avapritinib Tablets Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Avapritinib Tablets Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Avapritinib Tablets Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Avapritinib Tablets Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Avapritinib Tablets Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Avapritinib Tablets Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Avapritinib Tablets Manufacturers, Product Type & Application
  13. 4.7 Global Avapritinib Tablets Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Avapritinib Tablets Market CR5 and HHI
  16. 4.8.2 2025 Avapritinib Tablets Tier 1, Tier 2, and Tier 3
5 Avapritinib Tablets Market by Type
  1. 5.1 Global Avapritinib Tablets Revenue by Type
  2. 5.1.1 Global Avapritinib Tablets Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Avapritinib Tablets Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Avapritinib Tablets Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Avapritinib Tablets Sales by Type
  6. 5.2.1 Global Avapritinib Tablets Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Avapritinib Tablets Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Avapritinib Tablets Sales Market Share by Type (2021-2032)
  9. 5.3 Global Avapritinib Tablets Price by Type
6 Avapritinib Tablets Market by Application
  1. 6.1 Global Avapritinib Tablets Revenue by Application
  2. 6.1.1 Global Avapritinib Tablets Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Avapritinib Tablets Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Avapritinib Tablets Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Avapritinib Tablets Sales by Application
  6. 6.2.1 Global Avapritinib Tablets Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Avapritinib Tablets Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Avapritinib Tablets Sales Market Share by Application (2021-2032)
  9. 6.3 Global Avapritinib Tablets Price by Application
7 Company Profiles
  1. 7.1 Blueprint Medicines
  2. 7.1.1 Blueprint Medicines Company Information
  3. 7.1.2 Blueprint Medicines Business Overview
  4. 7.1.3 Blueprint Medicines Avapritinib Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Blueprint Medicines Avapritinib Tablets Product Portfolio
  6. 7.1.5 Blueprint Medicines Recent Developments
  7. 7.2 CStone Pharmaceuticals
  8. 7.2.1 CStone Pharmaceuticals Company Information
  9. 7.2.2 CStone Pharmaceuticals Business Overview
  10. 7.2.3 CStone Pharmaceuticals Avapritinib Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 CStone Pharmaceuticals Avapritinib Tablets Product Portfolio
  12. 7.2.5 CStone Pharmaceuticals Recent Developments
8 North America
  1. 8.1 North America Avapritinib Tablets Market Size by Type
  2. 8.1.1 North America Avapritinib Tablets Revenue by Type (2021-2032)
  3. 8.1.2 North America Avapritinib Tablets Sales by Type (2021-2032)
  4. 8.1.3 North America Avapritinib Tablets Price by Type (2021-2032)
  5. 8.2 North America Avapritinib Tablets Market Size by Application
  6. 8.2.1 North America Avapritinib Tablets Revenue by Application (2021-2032)
  7. 8.2.2 North America Avapritinib Tablets Sales by Application (2021-2032)
  8. 8.2.3 North America Avapritinib Tablets Price by Application (2021-2032)
  9. 8.3 North America Avapritinib Tablets Market Size by Country
  10. 8.3.1 North America Avapritinib Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Avapritinib Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Avapritinib Tablets Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Avapritinib Tablets Market Size by Type
  2. 9.1.1 Europe Avapritinib Tablets Revenue by Type (2021-2032)
  3. 9.1.2 Europe Avapritinib Tablets Sales by Type (2021-2032)
  4. 9.1.3 Europe Avapritinib Tablets Price by Type (2021-2032)
  5. 9.2 Europe Avapritinib Tablets Market Size by Application
  6. 9.2.1 Europe Avapritinib Tablets Revenue by Application (2021-2032)
  7. 9.2.2 Europe Avapritinib Tablets Sales by Application (2021-2032)
  8. 9.2.3 Europe Avapritinib Tablets Price by Application (2021-2032)
  9. 9.3 Europe Avapritinib Tablets Market Size by Country
  10. 9.3.1 Europe Avapritinib Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Avapritinib Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Avapritinib Tablets Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Avapritinib Tablets Market Size by Type
  2. 10.1.1 China Avapritinib Tablets Revenue by Type (2021-2032)
  3. 10.1.2 China Avapritinib Tablets Sales by Type (2021-2032)
  4. 10.1.3 China Avapritinib Tablets Price by Type (2021-2032)
  5. 10.2 China Avapritinib Tablets Market Size by Application
  6. 10.2.1 China Avapritinib Tablets Revenue by Application (2021-2032)
  7. 10.2.2 China Avapritinib Tablets Sales by Application (2021-2032)
  8. 10.2.3 China Avapritinib Tablets Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Avapritinib Tablets Market Size by Type
  2. 11.1.1 Asia Avapritinib Tablets Revenue by Type (2021-2032)
  3. 11.1.2 Asia Avapritinib Tablets Sales by Type (2021-2032)
  4. 11.1.3 Asia Avapritinib Tablets Price by Type (2021-2032)
  5. 11.2 Asia Avapritinib Tablets Market Size by Application
  6. 11.2.1 Asia Avapritinib Tablets Revenue by Application (2021-2032)
  7. 11.2.2 Asia Avapritinib Tablets Sales by Application (2021-2032)
  8. 11.2.3 Asia Avapritinib Tablets Price by Application (2021-2032)
  9. 11.3 Asia Avapritinib Tablets Market Size by Country
  10. 11.3.1 Asia Avapritinib Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Avapritinib Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Avapritinib Tablets Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Avapritinib Tablets Market Size by Type
  2. 12.1.1 SAMEA Avapritinib Tablets Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Avapritinib Tablets Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Avapritinib Tablets Price by Type (2021-2032)
  5. 12.2 SAMEA Avapritinib Tablets Market Size by Application
  6. 12.2.1 SAMEA Avapritinib Tablets Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Avapritinib Tablets Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Avapritinib Tablets Price by Application (2021-2032)
  9. 12.3 SAMEA Avapritinib Tablets Market Size by Country
  10. 12.3.1 SAMEA Avapritinib Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Avapritinib Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Avapritinib Tablets Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Avapritinib Tablets Value Chain Analysis
  2. 13.1.1 Avapritinib Tablets Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Avapritinib Tablets Production Mode & Process
  6. 13.2 Avapritinib Tablets Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Avapritinib Tablets Distributors
  9. 13.2.3 Avapritinib Tablets Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst